Therapy Areas: Oncology
Zai Lab officially listed on Hong Kong Stock Exchange Main Board
28 September 2020 -

Zai Lab (SEHK:9688, NASDAQ:ZLAB), a Qiming portfolio company that says that it focuses on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world, has been officially listed on The Stock Exchange of Hong Kong Limited's Main Board, it was reported on Sunday.

The issue price is HKD562 per share in the secondary listing and the stock opens at HKD613.5 per share, an increase of 9.16%, with a market cap of HKD52.724bn.

The firm has been listed on NASDAQ since 2017.

Login
Username:

Password: